RCKT - Rocket Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development53,08414,7255,9946,472
Selling General and Administrative12,5864,8551,580368
Non Recurring----
Total Operating Expenses65,67019,5807,5746,840
Operating Income or Loss-65,670-19,580-7,574-6,840
Income from Continuing Operations
Total Other Income/Expenses Net-8,84821-1,568
Earnings Before Interest and Taxes-65,670-19,580-7,574-6,840
Interest Expense-6,039-6,039-6,039-14
Income Before Tax-74,518-19,578-7,573-8,408
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-74,518-19,578-7,573-8,408
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-74,518-19,578-7,573-8,408
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-74,518-19,578-7,573-8,408